Over the past few months, much has been written about the expansive U.S. sanctions against Russia and Belarus. At the same time, there are indications that other sanctions programs may be loosened. Export control regulators are spending a lot of energy on compliance investigations. Please join Michael E. Burke, Corporate partner and co-chair of the Life Sciences team, and Alan G. Minsk, partner, leader of the Food & Drug team, and co-chair of the Life Sciences team, for a complimentary webinar focusing on considerations related to export controls and trade sanctions.
This webinar will focus on a variety of topics, including:
• a discussion on how life sciences companies are affected by U.S. export controls and
• how those companies can develop a specific and nimble export controls compliance program.
There will be an opportunity for Q&A at the end of this webinar.
Credits: 1 hour of CLE credit is pending approval by the State Bar of Georgia.
Note: The presentation and audio for this webinar will be streamed through your computer. A dial-in number will not be provided.
To enhance your webinar experience with us, please make sure to close out of all other streaming services prior to joining the webinar. If you experience audio issues during the broadcast, hit the F5 button on your keyboard to refresh the webpage in your browser.